Position | Company | Period |
---|
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-09-25 | 2023-09-25 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
10 000
+32.8%
0,868 600 USD |
10 000 +32.8% | 0,86 | 8 600 USD | |
2022-12-21 | 2022-12-21 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
14 000
+84.7%
1,0214 266 USD |
14 000 +84.7% | 1,02 | 14 266 USD | |
2022-05-17 | 2022-05-17 |
Vigil Neuroscience Inc
(VIGL)
|
A Achat |
14 893
+1.0%
2,9744 189 USD |
14 893 +1.0% | 2,97 | 44 189 USD | |
2022-05-17 | 2022-05-16 |
Vigil Neuroscience Inc
(VIGL)
|
A Achat |
21 802
+1.4%
2,7660 221 USD |
21 802 +1.4% | 2,76 | 60 221 USD | |
2022-03-28 | 2022-03-28 |
Vigil Neuroscience Inc
(VIGL)
|
A Achat |
3 000
+inf%
7,2021 604 USD |
3 000 +inf% | 7,20 | 21 604 USD | |
2022-01-11 | 2022-01-11 |
Vigil Neuroscience Inc
(VIGL)
|
A Achat |
265 000
+21.1%
14,003 710 000 USD |
265 000 +21.1% | 14,00 | 3 710 000 USD | |
2021-02-12 | 2021-02-10 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
32 873
-0.9%
4,43145 627 USD |
32 873 -0.9% | 4,43 | 145 627 USD | |
2020-11-24 | 2020-11-24 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
2 000
+9.5%
3,507 000 USD |
2 000 +9.5% | 3,50 | 7 000 USD | |
2020-11-24 | 2020-11-23 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
3 000
+16.7%
3,6711 010 USD |
3 000 +16.7% | 3,67 | 11 010 USD | |
2019-07-03 | 2019-07-01 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
459
-0.1%
14,006 426 USD |
459 -0.1% | 14,00 | 6 426 USD | |
2019-07-03 | 2019-07-01 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
255
-0.5%
14,003 570 USD |
255 -0.5% | 14,00 | 3 570 USD | |
2019-07-03 | 2019-07-01 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
180
-0.1%
14,002 520 USD |
180 -0.1% | 14,00 | 2 520 USD | |
2019-07-03 | 2019-07-01 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
2 014
-0.1%
14,0028 196 USD |
2 014 -0.1% | 14,00 | 28 196 USD | |
2019-06-20 | 2019-06-18 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
63
-0.0%
14,00882 USD |
63 -0.0% | 14,00 | 882 USD | |
2019-06-20 | 2019-06-18 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
35
-0.1%
14,00490 USD |
35 -0.1% | 14,00 | 490 USD | |
2019-06-20 | 2019-06-18 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
25
-0.0%
14,00350 USD |
25 -0.0% | 14,00 | 350 USD | |
2019-06-20 | 2019-06-18 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
VP Vente planifiée |
277
-0.0%
14,003 878 USD |
277 -0.0% | 14,00 | 3 878 USD | |
2018-12-06 | 2018-12-06 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
8 000
+inf%
1,3610 880 USD |
8 000 +inf% | 1,36 | 10 880 USD | |
2018-12-06 | 2018-12-04 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
4 000
+33.9%
3,1312 520 USD |
4 000 +33.9% | 3,13 | 12 520 USD | |
2018-10-24 | 2018-10-22 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
150 000
+56.3%
5,00750 000 USD |
150 000 +56.3% | 5,00 | 750 000 USD | |
2018-10-24 | 2018-10-22 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
12 487
+8.3%
5,0062 435 USD |
12 487 +8.3% | 5,00 | 62 435 USD | |
2018-10-24 | 2018-10-22 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
137 513
+8.2%
5,00687 565 USD |
137 513 +8.2% | 5,00 | 687 565 USD | |
2018-05-21 | 2018-05-18 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
61 139
-1.7%
13,16804 589 USD |
61 139 -1.7% | 13,16 | 804 589 USD | |
2018-05-21 | 2018-05-17 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
100 000
-2.8%
13,031 303 000 USD |
100 000 -2.8% | 13,03 | 1 303 000 USD | |
2018-03-23 | 2018-03-23 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
5 231
-0.1%
12,0262 877 USD |
5 231 -0.1% | 12,02 | 62 877 USD | |
2018-03-23 | 2018-03-22 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
33 630
-0.9%
12,07405 914 USD |
33 630 -0.9% | 12,07 | 405 914 USD | |
2018-03-23 | 2018-03-21 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
100 000
-2.7%
12,271 227 000 USD |
100 000 -2.7% | 12,27 | 1 227 000 USD | |
2017-12-07 | 2017-12-07 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
5 000
-0.1%
6,1330 650 USD |
5 000 -0.1% | 6,13 | 30 650 USD | |
2017-12-07 | 2017-12-06 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
6,0991 350 USD |
15 000 -0.4% | 6,09 | 91 350 USD | |
2017-12-07 | 2017-12-05 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
6,3795 550 USD |
15 000 -0.4% | 6,37 | 95 550 USD | |
2017-11-16 | 2017-11-16 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
5 000
-0.1%
6,9934 950 USD |
5 000 -0.1% | 6,99 | 34 950 USD | |
2017-11-16 | 2017-11-15 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
6,99104 850 USD |
15 000 -0.4% | 6,99 | 104 850 USD | |
2017-11-16 | 2017-11-14 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
7,02105 300 USD |
15 000 -0.4% | 7,02 | 105 300 USD | |
2017-10-05 | 2017-10-05 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
6 000
-0.2%
8,3450 040 USD |
6 000 -0.2% | 8,34 | 50 040 USD | |
2017-10-05 | 2017-10-04 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
14 000
-0.4%
8,59120 260 USD |
14 000 -0.4% | 8,59 | 120 260 USD | |
2017-10-05 | 2017-10-03 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
8,64129 600 USD |
15 000 -0.4% | 8,64 | 129 600 USD | |
2017-09-15 | 2017-09-15 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
10 000
-0.3%
7,5475 400 USD |
10 000 -0.3% | 7,54 | 75 400 USD | |
2017-09-15 | 2017-09-14 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
6 000
-0.2%
7,5245 120 USD |
6 000 -0.2% | 7,52 | 45 120 USD | |
2017-09-15 | 2017-09-13 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
8 500
-0.2%
7,4963 665 USD |
8 500 -0.2% | 7,49 | 63 665 USD | |
2017-08-09 | 2017-08-09 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
7,30109 500 USD |
15 000 -0.4% | 7,30 | 109 500 USD | |
2017-08-09 | 2017-08-08 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
5 000
-0.1%
7,9839 900 USD |
5 000 -0.1% | 7,98 | 39 900 USD | |
2017-08-09 | 2017-08-07 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
4 500
-0.1%
8,0236 090 USD |
4 500 -0.1% | 8,02 | 36 090 USD | |
2017-05-19 | 2017-05-19 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 000
-0.4%
8,31124 650 USD |
15 000 -0.4% | 8,31 | 124 650 USD | |
2017-05-19 | 2017-05-18 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
9 000
-0.2%
8,4475 960 USD |
9 000 -0.2% | 8,44 | 75 960 USD | |
2017-05-17 | 2017-05-17 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
19 000
-0.5%
8,39159 410 USD |
19 000 -0.5% | 8,39 | 159 410 USD | |
2017-05-17 | 2017-05-16 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
9 544
-0.2%
8,6182 174 USD |
9 544 -0.2% | 8,61 | 82 174 USD | |
2017-05-17 | 2017-05-15 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 941
-0.4%
8,94142 513 USD |
15 941 -0.4% | 8,94 | 142 513 USD | |
2017-04-19 | 2017-04-19 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
2 030
-0.1%
7,3714 961 USD |
2 030 -0.1% | 7,37 | 14 961 USD | |
2017-04-19 | 2017-04-18 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
44 455
-1.1%
7,48332 523 USD |
44 455 -1.1% | 7,48 | 332 523 USD | |
2017-04-19 | 2017-04-17 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
22 000
-0.5%
7,43163 460 USD |
22 000 -0.5% | 7,43 | 163 460 USD | |
2017-03-17 | 2017-03-16 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
21 485
-0.5%
6,77145 453 USD |
21 485 -0.5% | 6,77 | 145 453 USD | |
2017-03-17 | 2017-03-15 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
47 000
-1.1%
6,47304 090 USD |
47 000 -1.1% | 6,47 | 304 090 USD | |
2017-02-22 | 2017-02-22 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
2 000
-0.0%
7,4914 980 USD |
2 000 -0.0% | 7,49 | 14 980 USD | |
2017-02-22 | 2017-02-21 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
25 000
-0.6%
7,55188 750 USD |
25 000 -0.6% | 7,55 | 188 750 USD | |
2017-02-17 | 2017-02-17 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
10 000
-0.2%
7,5475 400 USD |
10 000 -0.2% | 7,54 | 75 400 USD | |
2017-02-17 | 2017-02-16 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
14 000
-0.3%
7,58106 120 USD |
14 000 -0.3% | 7,58 | 106 120 USD | |
2017-02-17 | 2017-02-15 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
17 485
-0.4%
7,64133 585 USD |
17 485 -0.4% | 7,64 | 133 585 USD | |
2017-01-20 | 2017-01-20 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
8 000
-0.2%
7,7762 160 USD |
8 000 -0.2% | 7,77 | 62 160 USD | |
2017-01-20 | 2017-01-19 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
15 485
-0.4%
8,23127 442 USD |
15 485 -0.4% | 8,23 | 127 442 USD | |
2017-01-20 | 2017-01-18 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
25 000
-0.6%
8,64216 000 USD |
25 000 -0.6% | 8,64 | 216 000 USD | |
2017-01-20 | 2017-01-17 |
Clearside Biomedical Inc
(CLSD)
|
VP Vente planifiée |
20 000
-0.5%
8,92178 400 USD |
20 000 -0.5% | 8,92 | 178 400 USD | |
2016-06-07 | 2016-06-07 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
785 714
+22.6%
7,005 499 998 USD |
785 714 +22.6% | 7,00 | 5 499 998 USD | |
2016-06-07 | 2016-06-07 |
Clearside Biomedical Inc
(CLSD)
|
V Vente |
138
-0.0%
7,00966 USD |
138 -0.0% | 7,00 | 966 USD |